CIBC Asset Management’s Senti Biosciences Holdings SNTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-40
Closed -$8.28K – 1094
2023
Q2
$8.28K Hold
40
– – ﹤0.01% 1099
2023
Q1
$15.6K Buy
+40
New +$20.5K ﹤0.01% 1064

Other funds holding SNTI

CIBC Asset Management's SNTI Position: Q3 2023 in Review

CIBC Asset Management sold out of Senti Biosciences Holdings (SNTI) in Q3 2023, closing a stake of 40 shares — an estimated $8.28K sold.

CIBC Asset Management first reported a position in SNTI in Q1 2023 and held it in 2 quarters. The position peaked at $15.6K in Q1 2023. 23 funds tracked by Wall St. Rank hold SNTI as of Q3 2023.

  • CIBC Asset Management reported no remaining Senti Biosciences Holdings position as of Q3 2023 after selling out during the quarter.
  • CIBC Asset Management sold 40 Senti Biosciences Holdings shares in Q3 2023, an estimated $8.28K.
  • CIBC Asset Management first reported a position in Senti Biosciences Holdings in Q1 2023 and held it in 2 quarters.
  • CIBC Asset Management's Senti Biosciences Holdings position peaked at $15.6K in Q1 2023.
  • 23 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q3 2023.

Based on CIBC Asset Management's 13F filing for Q3 2023, filed 30 Oct 2023.